Literature DB >> 15550594

Symptomatic hypocalcaemia after treatment with zoledronic acid in a patient with multiple myeloma.

D Singh, N S Khaira, J S Sekhon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15550594     DOI： 10.1093/annonc/mdh479

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  4 in total

1.  Garcinia Cambogia-Induced Acute Hepatitis; Varenicline-Induced Parkinsonism; Resistant Hypocalcemia After Zoledronic Acid Administration; Zonisamide-Induced Acute Kidney Injury; Psychosis Associated with Guanfacine.

Authors:  Michael A Mancano
Journal:  Hosp Pharm       Date:  2015-07-31

2.  Zoledronic Acid for Treatment of Low Bone Mineral Density in Patients with Beta Thalassemia Major.

Authors:  Rahul Naithani; Tulika Seth; Nikhil Tandon; Jagdish Chandra; V P Choudhry; H Pati; Renu Saxena
Journal:  Indian J Hematol Blood Transfus       Date:  2018-03-27       Impact factor: 0.900

3.  Severe resistant hypocalcemia in multiple myeloma after zoledronic acid administration: a case report.

Authors:  Adrian P Noriega Aldave; Shikha Jaiswal
Journal:  J Med Case Rep       Date:  2014-10-23

Review 4.  Hypercalcaemia and hypocalcaemia: finding the balance.

Authors:  Jean-Jacques Body; Daniela Niepel; Giuseppe Tonini
Journal:  Support Care Cancer       Date:  2017-01-12       Impact factor: 3.603
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.